Soborg, Denmark

Poul Erik Pedersen

This inventor holds 19 USPTO granted patents and 13 published patent applications and 8 EPO patents. Top assignees: Novozymes A/s, Novo Nordisk A/s, Novozymes Pharma Biotec A/s. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Poul Erik Pedersen. Retrieved from https://idiyas.com/inventor/poul-erik-pedersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 31.6

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Soeborg, DK (1994 - 1997)
  • Bagsvaerd, DK (1998 - 2000)
  • Søborg, DK (2003 - 2006)
  • Farum, DK (2010 - 2014)
  • Soborg, DK (2011 - 2020)

Company Filing History:


Years Active: 1994-2020

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovations of Poul Erik Pedersen

Introduction

Poul Erik Pedersen, based in Soborg, Denmark, is a notable inventor with a remarkable portfolio of 15 patents. His innovative spirit and expertise have greatly contributed to advancements in the field of biotechnology. With a focus on creating efficient methods for genetic engineering, his work continues to pave the way for further discoveries and applications.

Latest Patents

Among his latest patents, Poul Erik Pedersen has developed groundbreaking methods in genetic constructs. One of his notable inventions, "Stably maintained multiple copies of at least two ORF in the same orientation," outlines a method for constructing a host cell capable of expressing a polypeptide of interest. This method integrates at least two Open Reading Frames (ORFs) onto the chromosome of the host cell.

Another significant patent is the "Microfluidic device screening method." This invention provides a systematic approach to screening a microbial host cell for desired properties using a microfluidic device. The method involves transforming a d-alanine racemase-deficient microbial host cell with a specific polynucleotide construct, followed by the screening of the transformed host cell for the property of interest, all conducted without externally provided d-alanine.

Career Highlights

Poul Erik Pedersen's career includes substantial roles in prominent companies, such as Novozymes A/S and Novozymes Pharma Biotec A/S. His tenure at these organizations allowed him to collaborate with talented professionals and work on critical projects that enhanced his expertise and contribution to the field.

Collaborations

Throughout his career, Poul Erik Pedersen has had the opportunity to work alongside notable colleagues, including Helle Outtrup and Preben Nielsen. These collaborations have fostered innovative ideas and further propelled advancements in their respective projects.

Conclusion

Poul Erik Pedersen's dedication to innovation and his impressive work in biotechnology through his patented inventions demonstrate a significant commitment to improving scientific processes. His contributions continue to impact the field and inspire future advancements in genetic engineering and related technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…